Fabio
98 lines
4.3 KiB
Markdown
98 lines
4.3 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Maryland Medical Assistance Program and Health Insurance – Specialty Drugs – Definition"
|
||
description: "Maryland Medical Assistance Program and Health Insurance – Specialty Drugs – Definition"
|
||
jurisdiction: "us/states/md"
|
||
legislature: "Maryland General Assembly"
|
||
session: "2020"
|
||
identifier: "HB 652"
|
||
citation: "Maryland HB 652 (2020)"
|
||
classification: ["bill"]
|
||
subjects: []
|
||
status: "enacted"
|
||
primary_sponsors: ["Adams", "Anderton", "Arikan", "Bagnall", "Belcastro", "Bhandari", "Carr", "Charles", "Chisholm", "Clark", "Cullison", "Hill", "Hornberger", "Johnson", "K. Young", "Kelly", "Kerr", "Kipke", "Krebs", "Malone", "McComas", "Metzgar", "Morgan", "Pena-Melnyk", "Pendergrass", "R. Lewis", "Reilly", "Rosenberg", "Saab", "Szeliga"]
|
||
version_count: 3
|
||
action_count: 12
|
||
vote_count: 1
|
||
first_action: "2020-01-29"
|
||
last_action: "2020-05-08"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/52967f0a-a521-4ec8-a4ce-ba608eb58eeb"
|
||
source_url: "http://mgaleg.maryland.gov/mgawebsite/Legislation/Details/hb0652?ys=2020RS&search=True"
|
||
source_hash: "f764666c36820739a21859bcaa8a65e93f6c968fd5acba67418b9c0e16ed13a4"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-md"]
|
||
---
|
||
|
||
# Maryland HB 652 (2020) — Maryland Medical Assistance Program and Health Insurance – Specialty Drugs – Definition
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **Chapter - Maryland Medical Assistance Program and Health Insurance – Specialty Drugs – Definition** (committee substitute) — [source](http://mgaleg.maryland.gov/2020RS/Chapters_noln/CH_614_hb0652t.pdf)
|
||
2. **First - Maryland Medical Assistance Program and Health Insurance – Specialty Drugs – Definition** (committee substitute) — [source](http://mgaleg.maryland.gov/2020RS/bills/hb/hb0652f.pdf)
|
||
3. **Third - Maryland Medical Assistance Program and Health Insurance – Specialty Drugs – Definition** (committee substitute) — [source](http://mgaleg.maryland.gov/2020RS/bills/hb/hb0652t.pdf)
|
||
|
||
## Votes
|
||
|
||
- On Third Reading (Emerg) — **133–0** (pass) · lower
|
||
|
||
## Sponsors
|
||
|
||
- Adams — primary (person)
|
||
- Anderton — primary (person)
|
||
- Arikan — primary (person)
|
||
- Bagnall — primary (person)
|
||
- Belcastro — primary (person)
|
||
- Bhandari — primary (person)
|
||
- Carr — primary (person)
|
||
- Charles — primary (person)
|
||
- Chisholm — primary (person)
|
||
- Clark — primary (person)
|
||
- Cullison — primary (person)
|
||
- Hill — primary (person)
|
||
- Hornberger — primary (person)
|
||
- Johnson — primary (person)
|
||
- K. Young — primary (person)
|
||
- Kelly — primary (person)
|
||
- Kerr — primary (person)
|
||
- Kipke — primary (person)
|
||
- Krebs — primary (person)
|
||
- Malone — primary (person)
|
||
- McComas — primary (person)
|
||
- Metzgar — primary (person)
|
||
- Morgan — primary (person)
|
||
- Pena-Melnyk — primary (person)
|
||
- Pendergrass — primary (person)
|
||
- R. Lewis — primary (person)
|
||
- Reilly — primary (person)
|
||
- Rosenberg — primary (person)
|
||
- Saab — primary (person)
|
||
- Szeliga — primary (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2020-01-29** First Reading Health and Government Operations `referral-committee`
|
||
- **2020-02-06** Hearing 2/27 at 1:00 p.m.
|
||
- **2020-03-12** Favorable with Amendments Report by Health and Government Operations `committee-passage-favorable`
|
||
- **2020-03-12** Favorable with Amendments { `committee-passage-favorable`
|
||
- **2020-03-12** Second Reading Passed with Amendments
|
||
- **2020-03-12** Third Reading Passed `passage`
|
||
- **2020-03-13** Referred Finance `referral-committee`
|
||
- **2020-03-15** Favorable Report by Finance `committee-passage-favorable`
|
||
- **2020-03-15** Favorable Adopted Second Reading Passed `committee-passage-favorable`
|
||
- **2020-03-16** Third Reading Passed `passage`
|
||
- **2020-03-17** Returned Passed
|
||
- **2020-05-08** Enacted under Article II, Section 17(c) of the Maryland Constitution - Chapter 614 `became-law`
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/52967f0a-a521-4ec8-a4ce-ba608eb58eeb`. Confidence: reported (aggregated from official Maryland legislature records).
|
||
|